Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for Lupus Nephritis and Persistent Proteinuria
NCT00508898Phase 4Withdrawn
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of calcitriol in systemic lupus erythematosus (SLE) and lupus nephritis (LN) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Change in Proteinuria at 1 year. Planned start May 2008; status: withdrawn.
02
Drugs
calcitriol
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00508898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508898.